美国 · SEC FORM 4
Annexon, Inc.
ANNX · Nasdaq · CIK 0001528115 · Healthcare · Biotechnology
内部人信号
3 位买方 · 3 条买入交易行 · $3.5M 买入总额
为什么有这个信号?
评分构成
每条进度条表示其对当前分数的贡献;权重和公式保持不变。
哪些因素限制了当前分数?
- ⚠ Cluster breadth is moderate · 3 insider(s), not 4+
- ⚠ 角色得分低 · 买入者中职位最高的是:PRESIDENT AND CEO(CEO、董事长和持股 10% 以上的股东得分最低)
Purchase-size comments are relative to the model scale. Average daily volume is a separate market-context diagnostic.
US-v1.2 按当前 180 天规则给合资格的股票买入打分。分数只表示研究的先后,不是收益预测或概率。回测没有显示美国分数越高、之后的表现越好。
内部人活动时间轴
申报人轨道展示最近 180 天。符号形状区分交易类型;卖出仅作为背景。
—
买方广度与集中度
Roles in the peak window: Director. Concentration uses priced qualifying P lines only and does not change the saved score.
信号历史
最新留档分数
- 72.5
- 72.4
- 72.3
- 72.1
- 71.8
Only scores saved when a full US scoring run completed are shown; gaps are not reconstructed.
近期 Form 4 活动
P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.
市场背景
市场背景补充近期价格表现与风险信息,不影响内部人信号。
价格表现
- 1M
- -2.9%
- 3M
- -28.6%
- 6M
- -31.3%
- 12M
- +27.6%
波动率与流动性
- 波动率
- 76.7%
- Beta
- —
- 平均每日成交额
- USD 12.4M
估值
- 市值
- —
- P/E
- —
基本面
- 利润率
- —
- ROE
- -97.7%
- 细分行业
- Biotechnology
市场数据
价格数据截至:2026-10-11 · 价格来源:OpenBB/yfinance; 成交量来自 本机价格缓存 (yfinance) · 来自 SEC 申报文件:ROE · 财年截止日:2025-12-31 · Status: PASS
空头余额
空头余额是券商向 FINRA 申报的外部背景数据,不影响内部人信号。
- 空头股数
- 32,009,914
- 上期报告
- 32,871,995
- 日均成交量
- 3,597,520
- 回补天数
- 8.9
FINRA 结算日:2026-09-30 · 获取日期 2026-10-12 · FINRA 股票空头余额 ↗. 这是股数,每月两个结算日之后约一周公布;不是占已发行股份的比例。
历史股票买入
Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.
| Transaction date | Reporting owner | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-09-24 | Love Douglas | 买入 (P) | Common Stock | 26,065 | USD 3.83 | USD 99,829 | SEC 申报 ↗ |
| 2026-05-28 | Satter Muneer A | 买入 (P) | Common Stock | 613,497 | USD 5.41 | USD 3,319,019 | SEC 申报 ↗ |
| 2026-05-11 | Carson William H. | 买入 (P) | Common Stock | 8,000 | USD 5.78 | USD 46,240 | SEC 申报 ↗ |
| 2026-04-10 | Carson William H. | 买入 (P) | Common Stock | 8,000 | USD 6.20 | USD 49,600 | SEC 申报 ↗ |
| 2026-03-10 | Carson William H. | 买入 (P) | Common Stock | 8,000 | USD 5.67 | USD 45,360 | SEC 申报 ↗ |
| 2025-12-30 | Carson William H. | 买入 (P) | Common Stock | 4,115 | USD 5.02 | USD 20,657 | SEC 申报 ↗ |
| 2025-12-01 | Choi Jung | 买入 (P) | Common Stock | 33,000 | USD 4.19 | USD 138,270 | SEC 申报 ↗ |
| 2025-12-01 | Carson William H. | 买入 (P) | Common Stock | 4,115 | USD 4.47 | USD 18,394 | SEC 申报 ↗ |
| 2025-11-21 | Satter Muneer A | 买入 (P) | Common Stock | 422,613 | USD 4.28 | USD 1,808,784 | SEC 申报 ↗ |
| 2025-11-20 | Satter Muneer A | 买入 (P) | Common Stock | 400,000 | USD 4.48 | USD 1,792,000 | SEC 申报 ↗ |
| 2025-11-19 | Satter Muneer A | 买入 (P) | Common Stock | 500,000 | USD 3.94 | USD 1,970,000 | SEC 申报 ↗ |
| 2025-11-18 | Satter Muneer A | 买入 (P) | Common Stock | 500,000 | USD 3.18 | USD 1,590,000 | SEC 申报 ↗ |
| 2025-11-17 | Satter Muneer A | 买入 (P) | Common Stock | 500,000 | USD 2.99 | USD 1,495,000 | SEC 申报 ↗ |
| 2025-10-30 | Carson William H. | 买入 (P) | Common Stock | 4,115 | USD 3.17 | USD 13,045 | SEC 申报 ↗ |
| 2025-09-30 | Carson William H. | 买入 (P) | Common Stock | 4,115 | USD 3.05 | USD 12,551 | SEC 申报 ↗ |
Form 4 申报证据
30 transaction lines in the latest 365-day window; 168 in local history.
| 日期 | 申报人 | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-09-24 | Love Douglas | 买入 (P) | Common Stock | 26,065 | USD 3.83 | USD 99,829 | SEC 申报 ↗ |
| 2026-06-11 | Yednock Ted | 期权行权/转换 (M) | Common Stock | 30,646 | USD 1.85 | USD 56,695 | SEC 申报 ↗ |
| 2026-05-28 | Satter Muneer A | 买入 (P) | Common Stock | 613,497 | USD 5.41 | USD 3,319,019 | SEC 申报 ↗ |
展开近期 Form 4 证据 (30 grouped rows)
| 日期 | 申报人 | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-09-24 | Love Douglas | 买入 (P) | Common Stock | 26,065 | USD 3.83 | USD 99,829 | SEC 申报 ↗ |
| 2026-06-11 | Yednock Ted | 期权行权/转换 (M) | Common Stock | 30,646 | USD 1.85 | USD 56,695 | SEC 申报 ↗ |
| 2026-05-28 | Satter Muneer A | 买入 (P) | Common Stock | 613,497 | USD 5.41 | USD 3,319,019 | SEC 申报 ↗ |
| 2026-05-11 | Carson William H. | 买入 (P) | Common Stock | 8,000 | USD 5.78 | USD 46,240 | SEC 申报 ↗ |
| 2026-04-10 | Carson William H. | 买入 (P) | Common Stock | 8,000 | USD 6.20 | USD 49,600 | SEC 申报 ↗ |
| 2026-03-10 | Carson William H. | 买入 (P) | Common Stock | 8,000 | USD 5.67 | USD 45,360 | SEC 申报 ↗ |
| 2026-03-02 | Yednock Ted | 卖出 (S) | Common Stock | 5,566 | USD 5.42 | USD 30,168 | SEC 申报 ↗ |
| 2026-03-02 | Overdorf Michael | 卖出 (S) | Common Stock | 4,339 | USD 5.42 | USD 23,517 | SEC 申报 ↗ |
| 2026-03-02 | Lew Jennifer | 卖出 (S) | Common Stock | 5,565 | USD 5.42 | USD 30,162 | SEC 申报 ↗ |
| 2026-03-02 | Dananberg Jamie | 卖出 (S) | Common Stock | 5,820 | USD 5.43 | USD 31,603 | SEC 申报 ↗ |
| 2026-03-02 | ARTIS DEAN RICHARD | 卖出 (S) | Common Stock | 5,894 | USD 5.43 | USD 32,004 | SEC 申报 ↗ |
| 2026-02-19 | Yednock Ted | 奖励/授予 (A) | Common Stock | 62,500 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-02-19 | Overdorf Michael | 奖励/授予 (A) | Common Stock | 62,500 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-02-19 | Lew Jennifer | 奖励/授予 (A) | Common Stock | 62,500 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-02-19 | Dananberg Jamie | 奖励/授予 (A) | Common Stock | 56,250 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-02-19 | ARTIS DEAN RICHARD | 奖励/授予 (A) | Common Stock | 62,500 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-02-18 | Yednock Ted | 卖出 (S) | Common Stock | 7,857 | USD 5.11 | USD 40,149 | SEC 申报 ↗ |
| 2026-02-18 | Overdorf Michael | 卖出 (S) | Common Stock | 6,225 | USD 5.10 | USD 31,747 | SEC 申报 ↗ |
| 2026-02-18 | Lew Jennifer | 卖出 (S) | Common Stock | 7,851 | USD 5.11 | USD 40,119 | SEC 申报 ↗ |
| 2026-02-18 | Dananberg Jamie | 卖出 (S) | Common Stock | 5,290 | USD 5.10 | USD 26,979 | SEC 申报 ↗ |
| 2026-02-18 | ARTIS DEAN RICHARD | 卖出 (S) | Common Stock | 5,290 | USD 5.10 | USD 26,979 | SEC 申报 ↗ |
| 2025-12-30 | Carson William H. | 买入 (P) | Common Stock | 4,115 | USD 5.02 | USD 20,657 | SEC 申报 ↗ |
| 2025-12-01 | Choi Jung | 买入 (P) | Common Stock | 33,000 | USD 4.19 | USD 138,270 | SEC 申报 ↗ |
| 2025-12-01 | Carson William H. | 买入 (P) | Common Stock | 4,115 | USD 4.47 | USD 18,394 | SEC 申报 ↗ |
| 2025-11-21 | Satter Muneer A | 买入 (P) | Common Stock | 422,613 | USD 4.28 | USD 1,808,784 | SEC 申报 ↗ |
| 2025-11-20 | Satter Muneer A | 买入 (P) | Common Stock | 400,000 | USD 4.48 | USD 1,792,000 | SEC 申报 ↗ |
| 2025-11-19 | Satter Muneer A | 买入 (P) | Common Stock | 500,000 | USD 3.94 | USD 1,970,000 | SEC 申报 ↗ |
| 2025-11-18 | Satter Muneer A | 买入 (P) | Common Stock | 500,000 | USD 3.18 | USD 1,590,000 | SEC 申报 ↗ |
| 2025-11-17 | Satter Muneer A | 买入 (P) | Common Stock | 500,000 | USD 2.99 | USD 1,495,000 | SEC 申报 ↗ |
| 2025-10-30 | Carson William H. | 买入 (P) | Common Stock | 4,115 | USD 3.17 | USD 13,045 | SEC 申报 ↗ |
Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.
快照与身份
| 快照日期 | 2026-10-18 |
|---|---|
| 排名版本 | US-v1.2 |
| 数据质量 | PASS ELIGIBLE · — |
| 股票代码 | ANNX |
| CIK | 0001528115 |
| 行业 | Healthcare |
| 细分行业 | Biotechnology Yahoo Finance |
| SEC SIC | 2834 Pharmaceutical Preparations |
| 交易所 | Nasdaq |
数据覆盖
| 本地 Form 4 历史 | 168 transaction lines from 2020-07-28 to 2026-09-24 36 P purchase lines · 70 S sale lines · 62 other lines |
|---|---|
| SEC 公司申报 | 打开 SEC 申报 ↗ |
Local ledger as of 2026-10-18. Mapping status is an audit field and does not erase SEC filing evidence.